{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Albuterol+sulfate", "query": { "intervention": "Albuterol sulfate" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 381, "total_pages": 39, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Albuterol+sulfate&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-19T01:50:49.366Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02245672", "title": "MGR001 / Advair Diskus Local Equivalence Study in Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate)", "type": "DRUG" }, { "name": "Advair (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharma UK Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1128, "start_date": "2014-10", "completion_date": "2015-07", "has_results": true, "last_update_posted_date": "2022-02-24", "last_synced_at": "2026-09-19T01:50:49.366Z", "location_count": 101, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Anaheim, California + 84 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Bakersfield", "state": "California" }, { "city": "Burbank", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02245672" }, { "nct_id": "NCT02766673", "title": "Aerosolized Albuterol Use in Severe BPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Severe Bronchopulmonary Dysplasia" ], "interventions": [ { "name": "Albuterol Sulfate", "type": "DRUG" }, { "name": "Sterile Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "1 Year", "sex": "ALL", "summary": "Up to 1 Year" }, "enrollment_count": 24, "start_date": "2016-08", "completion_date": "2018-06", "has_results": true, "last_update_posted_date": "2019-08-28", "last_synced_at": "2026-09-19T01:50:49.366Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02766673" }, { "nct_id": "NCT07052942", "title": "Individualizing Treatment for Asthma in Primary Care (Full Study)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma", "Asthma Attack", "Asthma Exacerbations" ], "interventions": [ { "name": "Inhaled corticosteroid (ICS)", "type": "DRUG" }, { "name": "Azithromycin", "type": "DRUG" }, { "name": "Asthma Symptom Monitoring Web-based Application", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "DARTNet Institute", "sponsor_class": "OTHER_GOV", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "13 Years to 75 Years" }, "enrollment_count": 3200, "start_date": "2025-08-01", "completion_date": "2029-11-15", "has_results": false, "last_update_posted_date": "2025-10-29", "last_synced_at": "2026-09-19T01:50:49.366Z", "location_count": 13, "location_summary": "Aurora, Colorado • Orlando, Florida • Kansas City, Kansas + 9 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Orlando", "state": "Florida" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07052942" }, { "nct_id": "NCT02483975", "title": "Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FF", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Montelukast", "type": "DRUG" }, { "name": "Albuterol/Salbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "5 Years to 11 Years" }, "enrollment_count": 111, "start_date": "2015-10-09", "completion_date": "2016-06-21", "has_results": true, "last_update_posted_date": "2020-04-27", "last_synced_at": "2026-09-19T01:50:49.366Z", "location_count": 14, "location_summary": "Little Rock, Arkansas • Alhambra, California • Costa Mesa, California + 8 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Alhambra", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02483975" }, { "nct_id": "NCT03373409", "title": "Safety and Pharmacokinetics of Halix(TM) Albuterol Unit Dose Disposable Inhaler Versus Albuterol MDI", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol DPI 90mcg", "type": "DRUG" }, { "name": "Albuterol DPI 180mcg", "type": "DRUG" }, { "name": "Albuterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Concentrx Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 12, "start_date": "2017-11-30", "completion_date": "2018-07-25", "has_results": false, "last_update_posted_date": "2019-01-30", "last_synced_at": "2026-09-19T01:50:49.366Z", "location_count": 1, "location_summary": "Raleigh, North Carolina", "locations": [ { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03373409" }, { "nct_id": "NCT00665600", "title": "Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "Levalbuterol HCl", "type": "DRUG" }, { "name": "Albuterol Sulfate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "35 Years to 99 Years" }, "enrollment_count": 257, "start_date": "2002-02", "completion_date": "2003-03", "has_results": false, "last_update_posted_date": "2023-06-27", "last_synced_at": "2026-09-19T01:50:49.366Z", "location_count": 20, "location_summary": "Carmichael, California • Spring Valley, California • Wheat Ridge, Colorado + 17 more", "locations": [ { "city": "Carmichael", "state": "California" }, { "city": "Spring Valley", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Largo", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00665600" }, { "nct_id": "NCT01772147", "title": "Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder (62.5 or 125mcg) Once-daily Over 12 Weeks.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Umeclidinium bromide 62.5mcg", "type": "DRUG" }, { "name": "Umeclidinium bromide 125mcg", "type": "DRUG" }, { "name": "Fluticasone propionate 250mcg/Salmeterol 50mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 608, "start_date": "2013-01", "completion_date": "2013-08", "has_results": true, "last_update_posted_date": "2017-03-23", "last_synced_at": "2026-09-19T01:50:49.366Z", "location_count": 17, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Huntington Beach, California + 13 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Huntington Beach", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01772147" }, { "nct_id": "NCT02649478", "title": "Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone / Salmeterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Advair Diskus 100/50", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roxane Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1430, "start_date": "2014-08", "completion_date": "2015-11", "has_results": false, "last_update_posted_date": "2018-01-23", "last_synced_at": "2026-09-19T01:50:49.366Z", "location_count": 100, "location_summary": "Glendale, Arizona • Phoenix, Arizona • Surprise, Arizona + 75 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Surprise", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02649478" }, { "nct_id": "NCT00346749", "title": "ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Salmeterol", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol Combination Product", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 180, "start_date": "2006-12", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-09-19T01:50:49.366Z", "location_count": 11, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Diego, California + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00346749" }, { "nct_id": "NCT05848115", "title": "BiPAP in Pediatric Moderate to Severe Asthma Randomized Control Trial", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma in Children" ], "interventions": [ { "name": "Bi-level Positive Airway Pressure", "type": "DEVICE" }, { "name": "Sham Bi-level Positive Airway Pressure", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "5 Years to 17 Years" }, "enrollment_count": 67, "start_date": "2023-06-23", "completion_date": "2025-07-07", "has_results": false, "last_update_posted_date": "2025-08-21", "last_synced_at": "2026-09-19T01:50:49.366Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05848115" } ] }